Login / Signup

Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy.

Lina van der StratenAvinash G DinmohamedPeter E WesterweelAnton W LangerakJurgen RiedlJeanette K DoorduijnArnon P KaterMark-David Levin
Published in: Leukemia & lymphoma (2018)
Keyphrases
  • chronic lymphocytic leukemia
  • locally advanced
  • squamous cell carcinoma
  • radiation therapy
  • cell therapy
  • bone marrow